Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$13.01 - $15.77 $1.49 Million - $1.81 Million
114,512 New
114,512 $1.59 Million
Q4 2023

Feb 14, 2024

BUY
$11.67 - $20.73 $351,932 - $625,154
30,157 New
30,157 $487,000
Q2 2023

Aug 14, 2023

BUY
$14.1 - $19.83 $3.64 Million - $5.12 Million
257,992 Added 376.67%
326,485 $5.25 Million
Q1 2023

May 15, 2023

BUY
$9.09 - $19.45 $599,549 - $1.28 Million
65,957 Added 2600.83%
68,493 $1.19 Million
Q4 2022

Feb 14, 2023

SELL
$6.45 - $12.07 $146,885 - $274,870
-22,773 Reduced 89.98%
2,536 $23,000
Q3 2022

Nov 14, 2022

SELL
$7.86 - $12.91 $11.8 Million - $19.4 Million
-1,504,832 Reduced 98.35%
25,309 $218,000
Q2 2022

Aug 15, 2022

BUY
$7.06 - $13.97 $8.97 Million - $17.8 Million
1,270,632 Added 489.63%
1,530,141 $12.5 Million
Q1 2022

May 16, 2022

SELL
$12.15 - $35.28 $1.66 Million - $4.81 Million
-136,372 Reduced 34.45%
259,509 $3.15 Million
Q4 2021

Feb 14, 2022

BUY
$30.49 - $48.49 $12.1 Million - $19.2 Million
395,881 New
395,881 $13.5 Million
Q2 2021

Aug 16, 2021

SELL
$36.62 - $51.69 $5.38 Million - $7.59 Million
-146,931 Closed
0 $0
Q1 2021

May 17, 2021

BUY
$41.56 - $59.88 $6.11 Million - $8.8 Million
146,931 New
146,931 $7.09 Million
Q1 2020

May 15, 2020

SELL
$20.5 - $34.53 $879,901 - $1.48 Million
-42,922 Closed
0 $0
Q4 2019

Feb 14, 2020

BUY
$18.96 - $29.84 $813,801 - $1.28 Million
42,922 New
42,922 $1.26 Million
Q3 2019

Nov 14, 2019

SELL
$19.12 - $26.24 $1.8 Million - $2.48 Million
-94,386 Closed
0 $0
Q2 2019

Aug 14, 2019

BUY
$19.57 - $24.1 $1.32 Million - $1.63 Million
67,468 Added 250.64%
94,386 $2.07 Million
Q1 2019

May 15, 2019

BUY
$12.14 - $20.46 $326,784 - $550,742
26,918 New
26,918 $551,000

Others Institutions Holding NEO

About NEOGENOMICS INC


  • Ticker NEO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 125,796,000
  • Market Cap $2.06B
  • Description
  • NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...
More about NEO
Track This Portfolio

Track Balyasny Asset Management LLC Portfolio

Follow Balyasny Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Balyasny Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Balyasny Asset Management LLC with notifications on news.